Cited by 27Mesenchymal stem cell researchAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Oxidative Stress Mediates Depot-Specific Functional Differences of Human Adipose-Derived Stem Cells

Open access
Sriram, Sandhya, Yuan, Chengxiang, Chakraborty, Smarajit, Tay, Winson, Park, Min, Shabbir, Asim, Toh, Sue-Anne, Han, Weiping +1 more·2019·Stem Cell Research & Therapy

Abstract

BACKGROUND: Visceral (VS) fat depot is known to have defective adipogenic functions compared to subcutaneous (SC) fat, but its mechanism of origin is unclear. OBJECTIVE: We tested our hypothesis that the degree of oxidative stress in adipose-derived stem cells (ASCs) from these depots may account for this difference. METHODS: ASCs were isolated from VS (omental region) and SC (abdominal region) fat depots of human subjects undergoing bariatric surgery. ASCs from VS and SC fat were investigated for their cellular characteristics in reactive oxygen species (ROS), metabolism, gene expression, proliferation, senescence, migration, and adipocyte differentiation. ASCs were also treated with antioxidant ascorbic acid (vitamin C). RESULTS: We found that human VS-derived ASCs exhibit excessive oxidative stress characterized by high reactive oxygen species (ROS), compared to SC-derived ASCs. Gene expression analyses indicate that the VS-ASCs exhibit higher levels of genes involved in pro-oxidant and pro-inflammatory pathways and lower levels of genes in antioxidant and anti-inflammatory pathways. VS-ASCs have impaired cellular functions compared to SC-ASCs, such as slower proliferation, early senescence, less migratory activity, and poor adipogenic capability in vitro. Treatment with ascorbic acid decreased ROS levels drastically in VS-ASCs. Ascorbic acid treatment substantially improved proliferation, senescence, migration, and adipogenic capacities of compromised ASCs caused by high ROS. CONCLUSIONS: This finding suggests the fat depot-specific differences of cellular defects originating from stem cell population. Considering clinical potentials of human ASCs for cell therapies, this also offers a possible strategy for improving their therapeutic qualities through antioxidants.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-019-1240-y

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sriram, S., Yuan, C., Chakraborty, S., Tay, W., Park, M., Shabbir, A., Toh, S.-A., Han, W., & Sugii, S.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • Duke-NUS Medical School (SG)
  • National University Hospital (SG)
  • National University of Singapore (SG)
Corresponding author
Sugii, Shigeki
Venue
Stem Cell Research & Therapy
Published
2019-05-21
Volume
10
Issue
1
Pages
141-141
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2947461116
Cited by
27
References
22
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 1
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • A*STAR BMRC
  • Singapore-China Joint Grant Project (#1412424003)
  • A*STAR Joint Council Office (DPG #1334k00083)
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
adipose-derived stem cells, oxidative stress, visceral fat, subcutaneous adipose tissue, reactive oxygen species, adipogenesis, cellular senescence, cell proliferation, cell migration, vitamin C, antioxidants, inflammation, bariatric surgery, cell therapy
MeSH terms
Cell Movement, Humans, Inflammation, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, Gene Expression Regulation, Developmental, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Bariatric Surgery, Subcutaneous Fat, Intra-Abdominal Fat, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review